Viewing StudyNCT04953104



Ignite Creation Date: 2024-05-06 @ 4:20 PM
Last Modification Date: 2024-10-26 @ 2:08 PM
Study NCT ID: NCT04953104
Status: RECRUITING
Last Update Posted: 2024-02-08
First Post: 2021-06-28

Brief Title: Nivolumab for the Treatment of Patients With Metastatic Urothelial Cancer With ARID1A Mutation and Stratify Response Based on CXCL13 Expression
Sponsor: MD Anderson Cancer Center
Organization: MD Anderson Cancer Center

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-09-21
Start Date Type: ACTUAL
Primary Completion Date: 2024-12-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2021-06-28
First Submit QC Date: June 28 2021
Study First Post Date: 2021-07-07
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-12
Last Update Post Date: 2024-02-08
Last Update Post Date Type: ACTUAL